Inactive Instrument

MERCK Kommanditgesellschaft auf Aktien Share Price Other OTC

Equities

MKKGY

US5893392093

Pharmaceuticals

Financials

Sales 2024 * 21.26B 22.82B 1,902B Sales 2025 * 22.52B 24.17B 2,015B Capitalization 65.35B 70.14B 5,847B
Net income 2024 * 2.96B 3.17B 264B Net income 2025 * 3.49B 3.74B 312B EV / Sales 2024 * 3.39 x
Net Debt 2024 * 6.72B 7.21B 601B Net Debt 2025 * 4.9B 5.26B 438B EV / Sales 2025 * 3.12 x
P/E ratio 2024 *
22 x
P/E ratio 2025 *
18.7 x
Employees -
Yield 2024 *
1.53%
Yield 2025 *
1.61%
Free-Float 29.71%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on MERCK Kommanditgesellschaft auf Aktien

Managers TitleAgeSince
Chief Executive Officer 62 13/20/13
Director of Finance/CFO 56 01/14/01
Director of Finance/CFO 53 26/19/26
Members of the board TitleAgeSince
Director/Board Member 75 09/14/09
Chairman 67 26/19/26
Director/Board Member 61 01/12/01
More insiders
Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows: - solutions and products for scientific and biotechnological research (44.2%); - pharmaceutical products (38.4%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.; - performance materials for the electronics industry (17.4%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc. Net sales are distributed geographically as follows: Germany (4.8%), Europe (24%), China (12.9%), Asia/Pacific (20.1%), the United States (26.8%), North America (1.6%), Latin America (6.3%), Middle East and Africa (3.5%).
Calendar
More about the company